|
11
|
114
|
1bljA |
Nmr ensemble of blk sh2 domain, 20 structures |
|
14
|
112
|
1fhsA |
The three-dimensional solution structure of the src homology domain-2 of the growth factor receptor bound protein-2, nmr, 18 structures |
|
14
|
107
|
1hctB |
Nmr structure of the human src sh2 domain complex |
|
14
|
114
|
1blkA |
Nmr ensemble of blk sh2 domain using chemical shift refinement, 20 structures |
|
11
|
106
|
1aouF |
Nmr structure of the fyn sh2 domain complexed with a phosphotyrosyl peptide, 22 structures |
|
13
|
109
|
1ab2A |
Three-dimensional solution structure of the src homology 2 domain of c-abl |
|
18
|
111
|
1bfiA |
Solution structure of the c-terminal sh2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase, nmr, 30 structures |
|
11
|
112
|
1csyA |
Syk tyrosine kinase c-terminal sh2 domain complexed with a phosphopeptidefrom the gamma chain of the high affinity immunoglobin g receptor, nmr |
|
17
|
95
|
1ghuA |
Nmr solution structure of growth factor receptor-bound protein 2 (grb2) sh2 domain, 24 structures |
|
181
|
581
|
1bg1A |
Transcription factor stat3b/dna complex |
|
155
|
575
|
1bf5A |
Tyrosine phosphorylated stat-1/dna complex |
|
164
|
581
|
4e68A |
Unphosphorylated stat3b core protein binding to dsdna |
|
21
|
114
|
3s9kA |
Crystal structure of the itk sh2 domain. |
|
24
|
101
|
3s8oA |
Crystal structure of the grb2 sh2 domain in complex with a pyxn-derived tripeptide |
|
23
|
101
|
3s8nA |
Crystal structure of the grb2 sh2 domain in complex with a pyxn-derived tripeptide |
|
153
|
522
|
5ibmA |
Structure of s502p, a cancer-associated mutation of the oncogenic phosphatase shp2 |
|
158
|
523
|
5i6vA |
Structure of f285s, a cancer-associated mutation of the oncogenic phosphatase shp2 |
|
107
|
303
|
5hkyA |
Crystal structure of c-cbl tkbd domain in complex with spry2 peptide (36-60, py55) refined to 1.8a resolution (p6 form) |
|
16
|
98
|
5cdwA |
Crystal structure analysis of a mutant grb2 sh2 domain (w121g) with a pyvnv peptide |
|
40
|
168
|
5bo4A |
Structure of socs2:elongin c:elongin b from dmso-treated crystals |
|
29
|
108
|
4f59A |
Triple mutant src sh2 domain |
|
28
|
108
|
4f5bA |
Triple mutant src sh2 domain bound to phosphotyrosine |
|
54
|
243
|
4ey0A |
Structure of tandem sh2 domains from plcgamma1 |
|
58
|
243
|
4fbnA |
Insights into structural integration of the plcgamma regulatory region and mechanism of autoinhibition and activation based on key roles of sh2 domains |
|
28
|
108
|
4f5aA |
Triple mutant src sh2 domain bound to phosphate ion |
|
24
|
101
|
4eihA |
Crystal structure of arg sh2 domain |
|
107
|
377
|
4e93A |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes)in complex with tae684 |
|
154
|
526
|
4dgpA |
The wild-type src homology 2 (sh2)-domain containing protein tyrosine phosphatase-2 (shp2) |
|
162
|
525
|
4dgxA |
Leopard syndrome-associated shp2/y279c mutant |
|
32
|
163
|
4d8kA |
Crystal structure of a sh3-sh2 domains of a lymphocyte-specific protein tyrosine kinase (lck) from homo sapiens at 2.36 a resolution |
|
123
|
388
|
4a4bA |
Structure of modified phosphotyr371-c-cbl-ubch5b-zap-70 complex |
|
132
|
390
|
3zniA |
Structure of phosphotyr363-cbl-b - ubch5b-ub - zap-70 peptide complex |
|
122
|
388
|
4a4cA |
Structure of phosphotyr371-c-cbl-ubch5b-zap-70 complex |
|
117
|
447
|
3vs6A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate |
|
24
|
96
|
3wa4A |
Grb2 sh2 domain/cd28-derived peptide complex |
|
104
|
305
|
3vrrA |
Crystal structure of the tyrosine kinase binding domain of cbl-c (pl mutant) in complex with phospho-egfr peptide |
|
116
|
447
|
3vs2A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
103
|
309
|
3vrpA |
Crystal structure of the tyrosine kinase binding domain of cbl-c in complex with phospho-egfr peptide |
|
98
|
309
|
3vrnA |
Crystal structure of the tyrosine kinase binding domain of cbl-c |
|
112
|
447
|
3vs1A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea |
|
117
|
447
|
3vrzA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea |
|
95
|
310
|
3vrqA |
Crystal structure of the tyrosine kinase binding domain of cbl-c (pl mutant) |
|
116
|
447
|
3vs5A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
122
|
447
|
3vryA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane |
|
100
|
308
|
3vroA |
Crystal structure of the tyrosine kinase binding domain of cbl-c in complex with phospho-src peptide |
|
110
|
447
|
3vs4A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2h-pyran-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
123
|
447
|
3vs3A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |
|
106
|
447
|
3vs7A |
Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
|
109
|
447
|
3vs0A |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor n-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide |
|
27
|
114
|
3uyoA |
Crystal structure of monobody sh13/abl1 sh2 domain complex |
